Literature DB >> 19019819

A novel receptor-induced activation site in the Nipah virus attachment glycoprotein (G) involved in triggering the fusion glycoprotein (F).

Hector C Aguilar1, Zeynep Akyol Ataman, Vanessa Aspericueta, Angela Q Fang, Matthew Stroud, Oscar A Negrete, Richard A Kammerer, Benhur Lee.   

Abstract

Cellular entry of paramyxoviruses requires the coordinated action of both the attachment (G/H/HN) and fusion (F) glycoproteins, but how receptor binding activates G to trigger F-mediated fusion during viral entry is not known. Here, we identify a receptor (ephrinB2)-induced allosteric activation site in Nipah virus (NiV) G involved in triggering F-mediated fusion. We first generated a conformational monoclonal antibody (monoclonal antibody 45 (Mab45)) whose binding to NiV-G was enhanced upon NiV-G-ephrinB2 binding. However, Mab45 also inhibited viral entry, and its receptor binding-enhanced (RBE) epitope was temperature-dependent, suggesting that the Mab45 RBE epitope on G may be involved in triggering F. The Mab45 RBE epitope was mapped to the base of the globular domain (beta6S4/beta1H1). Alanine scan mutants within this region that did not exhibit this RBE epitope were also non-fusogenic despite their ability to bind ephrinB2, oligomerize, and associate with F at wild-type (WT) levels. Although circular dichroism revealed conformational changes in the soluble ectodomain of WT NiV-G upon ephrinB2 addition, no such changes were detected with soluble RBE epitope mutants or short-stalk G mutants. Additionally, WT G, but not a RBE epitope mutant, could dissociate from F upon ephrinB2 engagement. Finally, using a biotinylated HR2 peptide to detect pre-hairpin intermediate formation, a cardinal feature of F-triggering, we showed that ephrinB2 binding to WT G, but not the RBE-epitope mutants, could trigger F. In sum, we implicate the coordinated interaction between the base of NiV-G globular head domain and the stalk domain in mediating receptor-induced F triggering during viral entry.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19019819      PMCID: PMC2615506          DOI: 10.1074/jbc.M807469200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase.

Authors:  S Crennell; T Takimoto; A Portner; G Taylor
Journal:  Nat Struct Biol       Date:  2000-11

2.  Physicochemical studies on the interaction of the calcium-binding protein (troponin C) with the inhibitory protein (troponin I) and calcium ions.

Authors:  W D McCubbin; R S Mani; C M Kay
Journal:  Biochemistry       Date:  1974-06-18       Impact factor: 3.162

3.  The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation.

Authors:  T Sergel; L W McGinnes; M E Peeples; T G Morrison
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

4.  Strength of envelope protein interaction modulates cytopathicity of measles virus.

Authors:  Richard K Plemper; Anthea L Hammond; Denis Gerlier; Adele K Fielding; Roberto Cattaneo
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

5.  Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusion.

Authors:  Matteo Porotto; Matthew Murrell; Olga Greengard; Anne Moscona
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

6.  Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III.

Authors:  Michael C Lawrence; Natalie A Borg; Victor A Streltsov; Patricia A Pilling; V Chandana Epa; Joseph N Varghese; Jennifer L McKimm-Breschkin; Peter M Colman
Journal:  J Mol Biol       Date:  2004-01-30       Impact factor: 5.469

Review 7.  The HIV Env-mediated fusion reaction.

Authors:  Stephen A Gallo; Catherine M Finnegan; Mathias Viard; Yossef Raviv; Antony Dimitrov; Satinder S Rawat; Anu Puri; Stewart Durell; Robert Blumenthal
Journal:  Biochim Biophys Acta       Date:  2003-07-11

8.  Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor binding.

Authors:  Kimberly A Bishop; Andrew C Hickey; Dimple Khetawat; Jared R Patch; Katharine N Bossart; Zhongyu Zhu; Lin-Fa Wang; Dimiter S Dimitrov; Christopher C Broder
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

9.  Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion.

Authors:  Viatcheslav Zaitsev; Mark von Itzstein; Darrin Groves; Milton Kiefel; Toru Takimoto; Allen Portner; Garry Taylor
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion.

Authors:  Charles J Russell; Karen L Kantor; Theodore S Jardetzky; Robert A Lamb
Journal:  J Cell Biol       Date:  2003-10-27       Impact factor: 10.539

View more
  54 in total

Review 1.  Modes of paramyxovirus fusion: a Henipavirus perspective.

Authors:  Benhur Lee; Zeynep Akyol Ataman
Journal:  Trends Microbiol       Date:  2011-04-20       Impact factor: 17.079

2.  Structural rearrangements of the central region of the morbillivirus attachment protein stalk domain trigger F protein refolding for membrane fusion.

Authors:  Nadine Ader; Melinda A Brindley; Mislay Avila; Francesco C Origgi; Johannes P M Langedijk; Claes Örvell; Marc Vandevelde; Andreas Zurbriggen; Richard K Plemper; Philippe Plattet
Journal:  J Biol Chem       Date:  2012-03-19       Impact factor: 5.157

3.  Differential rates of protein folding and cellular trafficking for the Hendra virus F and G proteins: implications for F-G complex formation.

Authors:  Shannon D Whitman; Everett Clinton Smith; Rebecca Ellis Dutch
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

4.  Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein.

Authors:  Jinhui Dong; Robert W Cross; Michael P Doyle; Nurgun Kose; Jarrod J Mousa; Edward J Annand; Viktoriya Borisevich; Krystle N Agans; Rachel Sutton; Rachel Nargi; Mahsa Majedi; Karla A Fenton; Walter Reichard; Robin G Bombardi; Thomas W Geisbert; James E Crowe
Journal:  Cell       Date:  2020-12-10       Impact factor: 41.582

5.  Stimulation of Nipah Fusion: Small Intradomain Changes Trigger Extensive Interdomain Rearrangements.

Authors:  Priyanka Dutta; Ahnaf Siddiqui; Mohsen Botlani; Sameer Varma
Journal:  Biophys J       Date:  2016-10-18       Impact factor: 4.033

6.  Mechanism for active membrane fusion triggering by morbillivirus attachment protein.

Authors:  Nadine Ader; Melinda Brindley; Mislay Avila; Claes Örvell; Branka Horvat; Georg Hiltensperger; Jürgen Schneider-Schaulies; Marc Vandevelde; Andreas Zurbriggen; Richard K Plemper; Philippe Plattet
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

7.  Probing the functions of the paramyxovirus glycoproteins F and HN with a panel of synthetic antibodies.

Authors:  Brett D Welch; Marcin Paduch; George P Leser; Zachary Bergman; Christopher A Kors; Reay G Paterson; Theodore S Jardetzky; Anthony A Kossiakoff; Robert A Lamb
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

8.  Fusion activation through attachment protein stalk domains indicates a conserved core mechanism of paramyxovirus entry into cells.

Authors:  Sayantan Bose; Albert S Song; Theodore S Jardetzky; Robert A Lamb
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

9.  Entry and fusion of emerging paramyxoviruses.

Authors:  Rebecca Ellis Dutch
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

10.  Bimolecular complementation of paramyxovirus fusion and hemagglutinin-neuraminidase proteins enhances fusion: implications for the mechanism of fusion triggering.

Authors:  Sarah A Connolly; George P Leser; Theodore S Jardetzky; Robert A Lamb
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.